Back to Capital World Investors

VRTX
Showing 8 of 28 quarters

Position history for Capital World Investors's holdings in VERTEX PHARMACEUTICALS INC

Capital World Investors holds 25.4M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $11.3B as of 2026-Q1. The position was decreased (-0.6% shares). VRTX represents 1.5% of Capital World Investors's portfolio.

Current Value

$11.3B

Current Shares

25.4M

Total Value Change

-$1.2B

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
25.4M
-0.6%
$11.3B1.5%$474.27
0
2025-Q4
Decreased
25.5M
-1.6%
$11.6B1.6%$453.74
0
2025-Q3
Decreased
25.9M
-9.8%
$10.1B1.4%$395.31
0
2025-Q2
Increased
28.7M
+0.7%
$12.8B1.9%$441.30
50
2025-Q1
Increased
28.5M
+0.7%
$13.8B2.2%$492.69
55
2024-Q4
Increased
28.3M
+5.7%
$11.4B1.7%$399.35
53
2024-Q3
Increased
26.8M
+0.4%
$12.5B1.9%$462.88
50
2024-Q2
Increased
26.7M
+4.5%
$12.5B2.0%$468.72
57

Other major holders of VRTX: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used